Zenotech Laboratories
Zenotech Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Zenotech Laboratories
Start SIPZenotech Laboratories Investment Rating
-
Master Rating:
-
Zenotech Laboratories has an operating revenue of Rs. 37.50 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 34% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 18% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 11 | 8 | 10 | 8 | 9 | 11 | 8 |
Operating Expenses Qtr Cr | 6 | 6 | 6 | 5 | 5 | 5 | 5 |
Operating Profit Qtr Cr | 4 | 3 | 4 | 4 | 4 | 6 | 3 |
Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 1 | 1 | 0 | 1 | 1 | 1 | -12 |
Net Profit Qtr Cr | 3 | 1 | 4 | 1 | 3 | 4 | 14 |
Zenotech Laboratories Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹66.31
- 50 Day
- ₹64.14
- 100 Day
- ₹61.23
- 200 Day
- ₹58.83
- 20 Day
- ₹66.65
- 50 Day
- ₹64.02
- 100 Day
- ₹59.89
- 200 Day
- ₹56.06
Zenotech Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 67.56 |
Second Resistance | 68.68 |
Third Resistance | 69.46 |
RSI | 51.99 |
MFI | 56.21 |
MACD Single Line | 0.81 |
MACD | 0.54 |
Support | |
---|---|
First Resistance | 65.66 |
Second Resistance | 64.88 |
Third Resistance | 63.76 |
Zenotech Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 15,187 | 1,518,700 | 100 |
Week | 19,831 | 1,983,100 | 100 |
1 Month | 20,882 | 1,989,265 | 95.26 |
6 Month | 44,686 | 3,148,549 | 70.46 |
Zenotech Laboratories Result Highlights
Zenotech Laboratories Synopsis
BSE-Medical-Diversified
Zenotech Laboratorie is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 42.42 Cr. and Equity Capital is Rs. 61.03 Cr. for the Year ended 31/03/2023. Zenotech Laboratories Ltd. is a Public Limited Listed company incorporated on 15/06/1989 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L27100TG1989PLC010122 and registration number is 010122.Market Cap | 405 |
Sales | 37 |
Shares in Float | 1.89 |
No of funds | 1 |
Yield |
Book Value | 4.93 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | 8 |
Alpha | -0.08 |
Beta | 1.32 |
Zenotech Laboratories
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 68.84% | 68.84% | 68.84% | 68.84% |
Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
Individual Investors | 22.5% | 22.58% | 22.67% | 22.65% |
Others | 8.65% | 8.57% | 8.48% | 8.5% |
Zenotech Laboratories Management
Name | Designation |
---|---|
Dr. Azadar Husain Asghar Mehdi Khan | Non Executive Director |
Mr. Jignesh Anantray Goradia | Non Executive Director |
Mr. Rakeshchandra Jagdishprasad Sinha | Non Executive Director |
Ms. Kavita Rakesh Shah | Independent Director |
Mr. Chintan Jitendra Shah | Independent Director |
Mr. Jagruti Prashant Sheth | Independent Director |
Zenotech Laboratories Forecast
Price Estimates
Zenotech Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-10-30 | Quarterly Results | |
2023-08-01 | Quarterly Results | |
2023-04-28 | Audited Results | |
2023-01-27 | Quarterly Results | |
2022-10-28 | Quarterly Results |
Zenotech Laboratories FAQs
What is Share Price of Zenotech Laboratories ?
Zenotech Laboratories share price is ₹66 As on 03 December, 2023 | 19:42
What is the Market Cap of Zenotech Laboratories ?
The Market Cap of Zenotech Laboratories is ₹407.1 Cr As on 03 December, 2023 | 19:42
What is the P/E ratio of Zenotech Laboratories ?
The P/E ratio of Zenotech Laboratories is 43.7 As on 03 December, 2023 | 19:42
What is the PB ratio of Zenotech Laboratories ?
The PB ratio of Zenotech Laboratories is 4.9 As on 03 December, 2023 | 19:42